China fines pharma firms over $50 million for price-fixing
China has imposed a combined fine of 362 million yuan ($50.4 million) on four pharmaceutical companies and related individuals for price-fixing in a high-profile antitrust case, the country’s market regulator said on Friday. The State Administration for Market Regulation said it had asked its Tianjin bureau to investigate and penalize the case, which it called…









